Two probing first rate investigative reports document how psychiatry’s treatments are shaped by "opinion leaders" whose professional recommendations are compromised by their substantial, largely undisclosed, financial ties to drug companies.
Dr. David Healy, a formidable critic of the iron grip pharmaceutical corporations wield on the practice of psychiatry as well as on psychiatry’s deficient journal reports, directs his criticism at drug regulators in an article in the current British Medical Journal (BMJ).
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
It is difficult to believe this latest announcement laying claim to a new "under treated" psychiatric disorder–Intermittent Explosive Disorder (IED) is not a parody !!
Two documented news reports provide evidence validating our charge that FDA officials and drug manufacturers.
Health Canada has taken constructive step to warn people with high blood pressure, heart disease and other medical ailments NOT to take psychostimulant drugs–which are essentially amphetamines.
GSK’s acknowledgement refutes the recent claims made in the official organ of the American Psychiatric Association, The American Journal of Psychiatry.
A feature article in the current issue of TIME Magazine, “When Colleges Go On Suicide Watch” is a blatant example of an “infomercial” that extends pharmaceutical compay advertising pages into the news pages in TIME magazine.
An investigative report in The Hartford Courant will undoubtedly lead to a Congressional investigation.
The report reveals that mentally unstable soldiers are being deployed to the Iraq front in violation of federal law.
GlaxoSmithKline Reverses Decade of Denial: in Clinical Trials Paxil Triggered Significantly More Suicide Attempts in Adults than Placebo
The Washington Post reveals that a shocking secret investigative report by a Nigerian government panel of medical experts concluded that Pfizer Pharmaceuticals conducted an unethical drug experiment in Nigeria in 1996.
Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering." Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis.
